טוען...
Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients
Background/Aim: More than half of deaths among hemodialysis patients are due to cardiovascular disease. This study examined whether intravenous administration of ferric carboxymaltose (FCM) has an impact on cardiovascular events in iron-deficient hemodialysis patients. Patients and Methods: We perfo...
שמור ב:
| הוצא לאור ב: | In Vivo |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
International Institute of Anticancer Research
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193293/ https://ncbi.nlm.nih.gov/pubmed/33910844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12419 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|